STOCK TITAN

[Form 4] Marpai, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Marpai, Inc. (MRAI) CEO, Director, and 10% Owner Damien Lamendola reported acquiring 550,000 shares of Class A Common Stock on 10/20/2025 at $0, reflecting vested RSUs.

Following the transaction, he reported 1,350,000 shares held directly and indirect holdings of 6,419,893 shares through HillCour Investment Fund, LLC and 931,674 shares through WellEnterprises USA, LLC, as disclosed in footnotes.

Marpai, Inc. (MRAI) CEO, Direttore e Proprietario del 10% Damien Lamendola ha riportato l'acquisto di 550.000 azioni della Class A Common Stock il 20/10/2025 a $0, riflettendo RSU maturate.

Dopo la transazione, ha riferito 1.350.000 azioni detenute direttamente e partecipazioni indirette di 6.419.893 azioni attraverso HillCour Investment Fund, LLC e 931.674 azioni tramite WellEnterprises USA, LLC, come riportato nelle note a piè di pagina.

Marpai, Inc. (MRAI) CEO, Director y Propietario del 10% Damien Lamendola reportó la adquisición de 550,000 acciones de Class A Common Stock el 20/10/2025 a $0, reflejando RSUs consolidadas.

Tras la transacción, reportó 1,350,000 acciones en propiedad directa y participaciones indirectas de 6,419,893 acciones a través de HillCour Investment Fund, LLC y 931,674 acciones a través de WellEnterprises USA, LLC, como se indica en las notas al pie.

Marpai, Inc. (MRAI)의 CEO, 이사 및 10% 소유주인 Damien Lamendola는 550,000주의 Class A 보통주를 2025-10-20$0에 취득했다고 보고했습니다. 이는 부여된 RSU가 vest된 것을 반영합니다.

거래 후 그는 1,350,000주를 직접 보유하고 있으며, HillCour Investment Fund, LLC를 통해 6,419,893주, WellEnterprises USA, LLC를 통해 931,674주의 간접 보유를 보유하고 있다고 보고했고, 이는 각주에 기재되어 있습니다.

Marpai, Inc. (MRAI) CEO, Directeur et Propriétaire à hauteur de 10%, Damien Lamendola a déclaré l'acquisition de 550 000 actions de la classe A le 20/10/2025 pour $0, reflétant des RSU acquises.

Suite à la transaction, il a déclaré détenir directement 1 350 000 actions et des détentions indirectes de 6 419 893 actions via HillCour Investment Fund, LLC et 931 674 actions via WellEnterprises USA, LLC, comme indiqué dans les notes de bas de page.

Marpai, Inc. (MRAI) CEO, Direktor und 10%-Eigentümer Damien Lamendola meldete den Erwerb von 550.000 Aktien der Class A Common Stock am 20.10.2025 zu $0, was vestete RSUs widerspiegelt.

Nach der Transaktion gab er an, direkt 1.350.000 Aktien gehalten zu haben und indirekte Holdings von 6.419.893 Aktien über HillCour Investment Fund, LLC und 931.674 Aktien über WellEnterprises USA, LLC, wie in den Fußnoten angegeben.

Marpai, Inc. (MRAI) الرئيس التنفيذي، المدير ومالك 10% Damien Lamendola أبلغ عن شراء 550,000 سهماً من أسهم Class A العادية في 20/10/2025 بسعر $0، مع عكس RSUs المستحقة.

بعد الصفقة، صرح بأنه يمتلك 1,350,000 سهماً بشكل مباشر وحيازات غير مباشرة تبلغ 6,419,893 سهماً عبر HillCour Investment Fund, LLC و 931,674 سهماً عبر WellEnterprises USA, LLC، كما ورد في الحواشي.

Marpai, Inc. (MRAI) 的首席执行官、董事及 10% 所有者 Damien Lamendola 报告在 2025/10/20$0 购买了 550,000 股 A 类普通股,反映了已归属的 RSU。

交易后,他报告直接持有 1,350,000 股,并通过 HillCour Investment Fund, LLC 间接持有 6,419,893 股,以及通过 WellEnterprises USA, LLC 间接持有 931,674 股,如脚注所述。

Positive
  • None.
Negative
  • None.

Insights

Routine Form 4 showing RSU vesting and updated ownership.

The filing records an equity grant: 550,000 Class A shares acquired at $0 on 10/20/2025, noted as RSUs deemed fully vested on issuance. This increases the reporting person’s direct stake to 1,350,000 shares.

Beneficial ownership also includes indirect positions of 6,419,893 shares via HillCour Investment Fund, LLC and 931,674 shares via WellEnterprises USA, LLC, with voting and dispositive power indicated in footnotes. The filing updates ownership; market impact depends on future disclosures.

Marpai, Inc. (MRAI) CEO, Direttore e Proprietario del 10% Damien Lamendola ha riportato l'acquisto di 550.000 azioni della Class A Common Stock il 20/10/2025 a $0, riflettendo RSU maturate.

Dopo la transazione, ha riferito 1.350.000 azioni detenute direttamente e partecipazioni indirette di 6.419.893 azioni attraverso HillCour Investment Fund, LLC e 931.674 azioni tramite WellEnterprises USA, LLC, come riportato nelle note a piè di pagina.

Marpai, Inc. (MRAI) CEO, Director y Propietario del 10% Damien Lamendola reportó la adquisición de 550,000 acciones de Class A Common Stock el 20/10/2025 a $0, reflejando RSUs consolidadas.

Tras la transacción, reportó 1,350,000 acciones en propiedad directa y participaciones indirectas de 6,419,893 acciones a través de HillCour Investment Fund, LLC y 931,674 acciones a través de WellEnterprises USA, LLC, como se indica en las notas al pie.

Marpai, Inc. (MRAI)의 CEO, 이사 및 10% 소유주인 Damien Lamendola는 550,000주의 Class A 보통주를 2025-10-20$0에 취득했다고 보고했습니다. 이는 부여된 RSU가 vest된 것을 반영합니다.

거래 후 그는 1,350,000주를 직접 보유하고 있으며, HillCour Investment Fund, LLC를 통해 6,419,893주, WellEnterprises USA, LLC를 통해 931,674주의 간접 보유를 보유하고 있다고 보고했고, 이는 각주에 기재되어 있습니다.

Marpai, Inc. (MRAI) CEO, Directeur et Propriétaire à hauteur de 10%, Damien Lamendola a déclaré l'acquisition de 550 000 actions de la classe A le 20/10/2025 pour $0, reflétant des RSU acquises.

Suite à la transaction, il a déclaré détenir directement 1 350 000 actions et des détentions indirectes de 6 419 893 actions via HillCour Investment Fund, LLC et 931 674 actions via WellEnterprises USA, LLC, comme indiqué dans les notes de bas de page.

Marpai, Inc. (MRAI) CEO, Direktor und 10%-Eigentümer Damien Lamendola meldete den Erwerb von 550.000 Aktien der Class A Common Stock am 20.10.2025 zu $0, was vestete RSUs widerspiegelt.

Nach der Transaktion gab er an, direkt 1.350.000 Aktien gehalten zu haben und indirekte Holdings von 6.419.893 Aktien über HillCour Investment Fund, LLC und 931.674 Aktien über WellEnterprises USA, LLC, wie in den Fußnoten angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lamendola Damien

(Last) (First) (Middle)
C/O MARPAI, INC.
615 CHANNELSIDE DRIVE, SUITE 207

(Street)
TAMPA FL 33602

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Marpai, Inc. [ MRAI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 6,419,893 I See footnote(2)
Class A Common Stock 10/20/2025 A 550,000(1) A $0 1,350,000 D
Class A Common Stock 931,674 I See footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The RSUs are deemed fully vested on the issuance date.
2. Held by HillCour Investment Fund, LLC, of which Mr. Lamendola is the Manager, and holds the voting and dispositive power over the securities held by HillCour Investment Fund, LLC.
3. Held by WellEnterprises USA, LLC, a wholly owned subsidiary of HillCour, Inc., which is wholly owned by HillCour Holding Corporation, a corporation controlled by Mr. Lamendola. Mr. Lamendola holds the voting and dispositive power over the securities held by WellEnterprises USA, LLC.
/s/ Damien Lamendola 10/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Marpai (MRAI) disclose in this Form 4?

Damien Lamendola acquired 550,000 Class A shares on 10/20/2025 at $0, reflecting RSUs deemed fully vested on issuance.

How many Marpai (MRAI) shares does the reporting person hold directly after the transaction?

He reported 1,350,000 shares held directly following the transaction.

What indirect holdings were disclosed for Marpai (MRAI)?

Indirect holdings include 6,419,893 shares via HillCour Investment Fund, LLC and 931,674 shares via WellEnterprises USA, LLC.

What roles does the reporting person hold at Marpai (MRAI)?

He is a Chief Executive Officer, Director, and 10% Owner.

What is the nature of the acquired Marpai (MRAI) shares?

They are RSUs that were deemed fully vested on the issuance date.

When did the reported Marpai (MRAI) transaction occur?

The transaction date is 10/20/2025.
Marpai Inc

OTC:MRAI

MRAI Rankings

MRAI Latest News

MRAI Latest SEC Filings

MRAI Stock Data

6.70M
4.05M
49.81%
10.8%
0.16%
Healthcare Plans
Services-misc Health & Allied Services, Nec
Link
United States
TAMPA